CPT® Code 90721

Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Haemophilus influenzae b vaccine (DTaP/Hib), for intramuscular use

The CPT® Code 90721 refers to the Diphtheria, tetanus toxoids, and acellular pertussis vaccine combined with the Haemophilus influenzae type b vaccine (DTaP/Hib), intended for intramuscular administration. This vaccine is designed to provide long-lasting immunity against specific bacterial infections by stimulating the body's immune system to produce antibodies. Toxoids, which are inactivated toxins produced by bacteria, play a crucial role in this process by training the immune system to recognize and combat the harmful effects of these toxins. The vaccine exposes the recipient's immune system to altered forms of the bacteria, prompting it to generate its own antibodies. This immunological memory ensures that the body can respond effectively upon subsequent exposures to the same pathogens. The DTaP component of the vaccine is a more refined version of the pertussis vaccine, known as acellular pertussis, which is associated with fewer side effects compared to the whole-cell pertussis vaccine. The combination of these vaccines not only protects against diphtheria and tetanus but also against pertussis and Haemophilus influenzae type b, thereby enhancing overall immunity and public health outcomes.